| Abstrakt: |
A recent study conducted by researchers at New Vision University explores the treatment of Superior Vena Cava Syndrome (SVCS), a condition caused by the obstruction or narrowing of the superior vena cava. The primary treatment for SVCS is balloon angioplasty with endovascular stenting, which has shown efficacy ranging from 95-100% in addressing SVCS. However, common complications post-procedure include SVC narrowing recurrence, airway constriction, and mortality, often linked to malignancy. The study emphasizes the need for tailored approaches and ongoing efforts to enhance patient outcomes, particularly in addressing the root cause of SVCS, which is frequently malignancy. [Extracted from the article] |
